$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
靶向药泰瑞沙进入医保了吗?
2025-10-19 11:44:20
Check Details
肺癌靶向药泰瑞沙说明书
2025-10-19 11:44:20
Check Details
泰瑞沙治疗什么病?
2025-10-19 11:44:20
Check Details
色瑞替尼是否进入医保?
2025-10-19 11:44:20
Check Details
色瑞替尼需要终身吃吗?
2025-10-19 11:44:20
Check Details
色瑞替尼售价多少钱?
2025-10-19 11:44:20
Check Details
色瑞替尼价格是多少?
2025-10-19 11:44:20
Check Details
色瑞替尼服用方法
2025-10-19 11:44:20
Check Details
色瑞替尼吃多久会耐药?
2025-10-19 11:44:20
Check Details
色瑞替尼多少钱?
2025-10-19 11:44:20
Check Details
色瑞替尼国内有吗?
2025-10-19 11:44:20
Check Details
色瑞替尼吃几天有效?
2025-10-19 11:44:20
Check Details
1
2
...
9694
9695
9696
9697
9698
9699
9700
...
10205
10206
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
RAS Targeted Therapy Resistance Breakthrough: mTORC1 is Key, Dalifarnib Combination Therapy Brings Hope
2
ARID1A Gene: A New Breakthrough in Tumor Immunotherapy, Turning "Cold Tumors" Hot
3
Alectinib for ALK-Positive Lung Cancer: Efficacy, Side Effects & Clinical Outlook
4
Mavacamten (Maifantuo): A Targeted Therapy for Obstructive Hypertrophic Cardiomyopathy
5
Remibrutinib (Ruipoduo): Safety, Side Effects, and Usage Guidelines
6
Which Generation TKI Is Repotrectinib? Professional Analysis of Next-Gen ROS1 Inhibitor Classification and Clinical Features
7
Brigatinib for NF2 Neurofibromatosis: Mechanism, Efficacy and Prospects
8
Dietary Guide During Goserelin Treatment: Scientific Nutrition Management to Alleviate Side Effects and Improve Quality of Life.
9
CYP26A1 Gene Emerges as New Target for Colorectal Cancer Treatment! Folate Metabolism Research Brings Hope for Immunotherapy.
10
Precision Breakthrough: Inavolisib Redefines Survival in PIK3CA-Mutant Breast Cancer
11
Romiplostim vs. Eltrombopag: ITP Treatment Dosing Differences and Precision Selection
12
Asciminib: Mechanism and Clinical Value of the First ABL Allosteric Inhibitor